SUMMARY The phenothiazine dixyrazine (5 mg • kg" 1 i.v.) had minimal, transient hypotensive effects but significantly reduced the leakage of m I labelled serum albumin in conscious rats subjected to acute hypertension provoked by i.v. adrenaline or bicuculline. By contrast, dixyrazine did not protect the blood-brain barrier during osmotic stress induced by intracarotid infusion of 2 M urea.
SOME DRUGS known to inhibit endo-or exocytosis in various membranes have been found to decrease the protein extravasation in the brain during acute hypertension, 1 " 6 and it has been postulated that the protection is mediated via inhibition of pinocytosis in cerebral endothelial cells. Among drugs shown to reduce protein extravasation during acute hypertension are some phenothiazines." Since drugs can also reduce protein leakage in this experimental model by enhancing the cerebrovascular tone, 1 it is important to rule out possible vasoconstrictory effects of phenothiazines before conclusions as to an effect on the endothelial cell membrane can be drawn. In the present study we have investigated the effect of a phenothiazine, dixyrazine, 78 on blood pressure, protein leakage over the blood-brain barrier during acute hypertension and on pial vessel diameter. Since it has been suggested that the mechanism behind hypertensive and osmotic opening of the blood-brain barrier may be the same (see Discussion), we likewise studied any dixyrazine effects on osmotic opening of the blood-brain barrier.
Materials and Methods Male Sprague-Dawley rats (200-225 g) were used. The numbers of animals in each group are shown in the tables.
Studies on Albumin Extravasation During Acute Hypertension
Indwelling catheters were inserted under methohexital anesthesia (BrietaP 50 mg • kg 1 ) into the ab-dominal aorta via the left femoral artery and the right jugular vein. The free ends of the catheters were exteriorized on the back of the neck. Two days later the aortic catheter was connected to a transducer and mean arterial pressure (MAP) recorded in conscious unrestrained rats. Arterial PC0 2 , P0 2 and pH were measured.
12B
I labelled human serum albumin (IHSA, 100 juCi • kg 1 ) and 0.5 ml 2 % Evans blue were given intravenously (i.v.) as indicators of the function of the blood-brain barrier. Evans blue binds to serum albumin in vivo and enables a macroscopic evaluation of albumin leakage. In addition, the colouring of the blood simplifies the recognition of satisfactory removal of blood by perfusion (see below). After administration of the tracers, the blood pressure was abruptly increased by i.v. injection of adrenaline (20 Mg • kg" 1 ) or bicuculline (1.2 mg • kg" 1 ). Bicuculline induces epileptic seizures, and the hemodynamic consequences, that is an abrupt increase in blood pressure combined with pronounced cerebral vasodilation, 10 enhance the cerebrovascular permeability to albumin. 11 It is known that i.v. administration of adrenaline or bicuculline in the doses used in the present study leads to easily detected albumin leakage in the brain in conscious rats. 12 Half of the rats were pretreated with dixyrazine (Esucos®, USB, 5 mg • kg" 1 i.v.) 15-20 min before the administration of the hypertensive drugs. The dose dixyrazine was chosen for being roughly equivalent to the doses of some phenotiazines used in an earlier study. 8 Three minutes after the blood pressure had reached its maximum levelwhich occurred within 5-30 s after the injection of bicuculline or adrenaline -the rats were given 30 mg • kg" 1 pentobarbital i.v. and the brains were perfused with physiological saline through the left heart ventricle for one minute to remove the tracers from the blood vessels. Pentobarbital was given rather than potassium chloride because it is important to start perfusion while the heart is still beating in order to get optimal perfusion of the cerebral vessels and thus remove the intravascular radioactivity.
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The brains were dissected as shown in table 2, the samples weighed and the radioactivity determined in a scintillation counter. The brain radioactivity was calculated as a ratio of the activity in brain versus blood, i.e. 100 X (CPM/mg brain tissue over CPM/mg blood). Statistical differences were evaluated with Wilcoxon's rank sum test.
Osmotic Opening of the Blood-Brain Barrier Catheters were inserted in the aorta and right jugular vein under methohexithal anesthesia in the same way as in rats subjected to acute hypertension. In addition, one catheter was inserted in the right external carotid artery with the tip of the catheter close to the carotid bifurcation. The superior thyroid, occipital, and pterygopalatine arteries were ligated (cf Johansson   13 ). All catheters were exteriorized on the back of the neck. Two days later 1.5 ml 2 M urea were infused for 30 seconds through the carotid catheter during continuous recording of MAP. Evans blue and m IHSA were used as tracers in the same doses as above, and controls were compared to rats pretreated with dixyrazine 5 ml • kg -1 or 15 mg • kg 1 . The lower dose was given 15-20 min before the infusion of urea (that is the same interval as in the hypertension experiments). Because of larger effects on blood pressure with higher doses (see results), the interval had to be extended to 40 min in this group. The radioactivity was determined in the right and left hemisphere and related to the activity in the blood as described above.
Determination of Pial Vessel Diameter
Six rats initially anesthetized with 30 mg • kg" 1 sodium pentobarbital (Nembutal) were tracheotomized, immobilized with 0.5 mg • kg" 1 tubocurarine chloride, and ventilated with a 3:1 mixture of N 2 0:0 2 in a small animal respirator (Harvard). Both femoral arteries and one femoral vein were cannulated for continuous recording of MAP, removal of blood for blood gas analyses, and for administration of drugs. Body temperature was controlled by a Philip's rectal thermosensor unit and maintained during the experiments between 37 and 38° Celsius by means of a heating pad. The head was fixed in a stereotaxic holder and a parasagittal cranial window inserted (for details see Auer 14 ). Pial vessels were observed through the closed cranial window using a Leitz intravital microscope and the lumen diameters measured with the aid of an attached TV multichannel videoangiometer. 15 Analysis of grey value changes on single TV lines crossing a pial vessel as shown on a TV monitor gives continuous information on diameter variations. With a three channel device three vessel portions were simultaneously and continuously analysed. The data, calibrated in /urn, were recorded on a pen recorder. Multiple replay of single experiments stored on videotape allowed the analysis of the whole vasculature visible under the microscope at fifty-fold magnification. Diameter variations were measured for at least 15 min before and 30 min after the injection of dixyrazine (5 mg • kg" 1 ). Statistical calculations were performed using Student's t-test.
Results

Albumin Extravasation in Acute Hypertension
Dixyrazine, 5 mg • kg 1 , induced a slight transitory decrease in blood pressure (10-20 mm Hg). At the time of induction of acute hypertension 15-20 min later the pressure had returned to the initial level. MAP before and after injection of the hypertensive drugs, as well as Pa0 2 , PaC0 2 and pH, is given in table 1. Maximum MAP was slightly but not significantly lower in dixyrazine-treated rats. There was no difference as to the abruptness or duration of the blood pressure response. As seen in table 2 dixyrazine reduced the radioactivity in the brain which corresponded to the macroscopic appearance of Evans blue albumin extravasation.
Albumin Extravasation in Osmotic Opening of the BloodBrain Barrier
There was no difference in arterial blood gas parameters between the experimental groups. As in the preceding group 5 mg • kg" 1 dixyrazine induced a transitory decrease in blood pressure. Dixyrazine 15 mg • kg" 1 lowered the blood pressure 40-65 mm Hg and at the time of urea infusion 40 min later MAP was 100 ± 1 mm Hg compared to 120 ± 2 for controls and 114 ± 2 for rats given the lower dose dixyrazine (p < 0.01 and p < 0.05 respectively). During the infusion of urea MAP rapidly increased to a maximum level 8-12 s after the start of the infusion. This initial rise was followed by a marked fall and then a second rise in MAP, see figure 1 which gives the mean values for the groups. Maximum MAP during the first rise in pressure was significantly lower in rats pretreated with dixyrazine 15 mg • kg" 1 (144 ± 6 mm Hg) than in controls (175 ± 4 mm Hg; p < 0.01). At no other times were there any statistically significant differences between the groups.
Some muscular twitchings were observed in most rats during the infusion of urea. When the injection ended there was no abnormal behaviour. There was no significant difference in albumin extravasation in the brain between the groups (table 3).
Determination of Pial Vessel Diameter
Thirty-four arteries (diameter 20-69 \ixa) and 19 veins (diameter 34-141 nm) were continuously observed and the diameters recorded. PaC0 2 was kept between 4.0 and 5.0 kPa and Pa0 2 > 14 kPa. The initial MAP was 104 ± 7 mm Hg. As in conscious rats, dixyrazine induced a transitory decrease in MAP (19 ± 11 mm Hg). A corresponding transient autoregulatory dilatation of pial arteries was recorded (p < 0.0005). An individual experiment is shown in figure 2 . Figure 3 demonstrates graphically the changes of arterial and venous vessel diameters as well as MAP during 10 minutes after injection of dixyrazine. The slight venous dilatation was not significant. Both MAP and vessel diameter returned to about initial levels within 5 minutes. Thus, there was no indication of any direct effect of dixyrazine on cerebrovascular tone.
Discussion
The present results are in agreement with earlier work showing that phenothiazines can protect the blood-brain barrier during acute hypertension. fact that dixyrazine reduced albumin leakage also in rats given bicuculline supports the hypothesis that the drug acts on the endothelial cell membrane because drugs which increase the cerebrovascular tone do not prevent albumin extravasation in this experimental model. Thus, indomethacin, which markedly enhances the cerebrovascular tone in conscious animals, 16 , " protects the blood-brain barrier during acute hypertension per se but has no effect on albumin leakage in the bicuculline model, 18 probably because the metabolically induced vasodilatation overrules the constrictory effect of the drug. The fact that dixyrazine did not enhance pial arterial tone further supports the hypothesis that the protective effect of phenothiazine during acute hypertension is not due to vasoconstriction.
The question whether the entry of macromolecules into the brain in acute hypertension is transendothelial or interendothelial has been much debated. Most recent reports seem to indicate that the passage is predominantly transendothelial (for references see Johansson 6 ) and there is evidence that tight junctions are highly resistant to mechanical trauma. 19 The influence of drugs on the blood-brain barrier opening seems to favour the hypothesis of transendothelial passage, although to our knowledge, the possibility of pharmacological effects on tight junctions has not been investigated and thus cannot be ruled out. It has recently been questioned whether pinocytotic vesicles in mesenteric vessels are in fact freely moving entities transferring substances from the luminal to the abluminal side of the endothelial cells or are part of cluster-like invaginations from the cell surface.
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Hansson et al 22 reported the presence of channels in cerebral vessels during acute hypertension and pointed out that vesicles filled with tracer substance in endothelial cells may either be interpreted as pinocytotic vesicles or regarded as being part of a channel system as earlier shown in muscle capillaries. 23 Evidence for the occurrence of transendothelial channels in cerebral vessels during acute hypertension has also been presented by Nag et al 24 and Auer. The hypothesis that tight junctions are opened during osmotic dysfunction of the blood-brain barrier 26 has recently been questioned. 19, 26, 27 Since hyperosmolar solutions induce vasodilatation and dilated vessels have an increased vulnerability to high intraluminal pressure it has been suggested that stretching of the vessel wall is of pathogenetic importance as in acute hypertension. The absence of a protective effect of dixyrazine on the osmotic blood-brain barrier opening does not support the hypothesis that the leakage is exclusively due to hemodynamic events but suggests that hyperosmolar solutions have some additional effect on endothelial cells. This does not rule out transendothelial passage since formation of pinocytotic vesicles seems to be a common reaction to cerebral trauma of various types (see Westergaard   28 ).
In conclusion, the present study shows that dixyrazine protects the blood-brain barrier during a hypertensive insult. Since dixyrazine has no constrictory effect on pial vessels the protection is probably mediated via a change in the endothelial cell membrane. DURING CHRONIC arterial hypertension there is an impairment of cerebral autoregulation. 1,2> 3 In normotensive subjects cerebral blood flow (CBF) may be maintained down to mean blood pressures of 60-70 torr, but CBF may decrease at pressures above 100 torr in hypertensive subjects. 4, 8 Impaired cerebral autoregulation has also been identified in spontaneously hypertensive rats (SHR). 8, 7 It is often desirable and necessary to control hypertension during intraoperative periods and to induce hypotension to reduce blood loss. 8, 9 Reductions in blood pressure increases the risk of cerebral ischemia in hypertensives more than in normotensive subjects. 10 One possible solution to this problem is the use of a hypotensive drug which also has direct cerebral vasodilating effects. Nitroglycerin (NTG) is a drug which has been suggested for use in hypotensive anesthesia. 8 This drug also has been reported to reverse cerebrovasospasm. 11 Although cerebrovasodilation has been reported dur- ing NTG induced hypotension, other reports have indicated that NTG treatment increases intracranial pressure and may decrease CBF. 18,13, u In these experiments the cerebrovascular effects of NTG induced hypotension were studied in anesthetized spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto controls (WKY).
